Alkem Laboratories Ltd.

NSE: ALKEM | BSE: 539523 | ISIN: INE540L01014 | Industry: Pharmaceuticals
| Mid-range Performer
5002.2000 69.00 (1.40%)
NSE Jul 16, 2025 15:50 PM
Volume: 208.3K
 

logo
Alkem Laboratories Ltd.
29 Sep 2016
5002.20
1.40%
Alkem Laboratories gets US FDA observations on Daman plant
Alkem Laboratories gets US FDA observations on Daman plant
livemint
Alkem Laboratories says it will prepare a detailed response with corrective and preventive measures to address the US FDA observations
Number of FII/FPI investors increased from 524 to 535 in Mar 2025 qtr.
US FDA issues thirteen 483 observations for Alkem's Daman facility
Business Standard | 30 Sep 2016 5 more
More from Alkem Laboratories Ltd.
Recommended
Market closes flat, ITC Hotels' Q1FY26 net profit beats Forecaster estimates by 35.5%
Trendlyne Marketwatch | 16 Jul 2025, 03:59PM
Five stocks to buy from analysts this week - July 15, 2025
The Baseline | 15 Jul 2025, 06:44PM
Alkem Laboratories hopes to fire up its US business to fuel future growth
| 02 Jul 2021